"Als größtes Universitätsklinikum im Norden deckt das UKSH mit 92 Kliniken und Instituten in Kiel und Lübeck das gesamte Spektrum der modernen Medizin ab. Mehr als 450.000 Patientinnen und Patienten profitieren jedes Jahr von der engen Verknüpfung der Spitzenmedizin des UKSH mit der innovativen Forschung der Universitäten in Kiel und Lübeck. Forschungsergebnisse gelangen hier direkt in die medizinische Praxis. Das Ergebnis ist ein exzellentes klinisches Niveau: Das UKSH ist Garant für höchst individualisierte sowie interdisziplinäre Diagnostik und Therapie. Wir entwickeln neue Perspektiven für Menschen mit schweren, seltenen und chronischen Erkrankungen. Das Wohlergehen unserer Patientinnen und Patienten steht im Mittelpunkt unseres Handelns"

During the past decade, UNI-Klinikum Campus Kiel Klinik für Gynäkologie und Geburtshilfe conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNI-Klinikum Campus Kiel Klinik für Gynäkologie und Geburtshilfe" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "German Breast Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "UNI-Klinikum Campus Kiel Klinik für Gynäkologie und Geburtshilfe" are "Breast Cancer" (3 trials), "Ovarian Cancer" (2 trials), "Breast Neoplasms" (1 trials), "Cancer of the Fallopian Tube" (1 trials) and "Epithelial Ovarian Cancer" (1 trials). Many other conditions were trialed in "UNI-Klinikum Campus Kiel Klinik für Gynäkologie und Geburtshilfe" in a lesser frequency.

Most popular intervention types in "UNI-Klinikum Campus Kiel Klinik für Gynäkologie und Geburtshilfe" are "Drug" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Trastuzumab" (2 trials), "5-Fluorouracil" (1 trials), "Atezolizumab" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNI-Klinikum Campus Kiel Klinik für Gynäkologie und Geburtshilfe" are 5 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "UNI-Klinikum Campus Kiel Klinik für Gynäkologie und Geburtshilfe". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in UNI-Klinikum Campus Kiel Klinik für Gynäkologie und Geburtshilfe, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UNI-Klinikum Campus Kiel Klinik für Gynäkologie und Geburtshilfe, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".